Nephros Inc (NEPH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nephros Inc (NEPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011282
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nephros Inc (Nephros) is medical device company that develops and markets filtration products. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters are intended to be used to filter water and bicarbonate concentrate used in hemodialysis devices to assist in providing hemodialysis quality water or bicarbonate concentrates. Nephros offers infection control filters such as ice machine solutions, shower solutions and sink products. The company’s products are used in conjunction with other water treatment equipment. Its dialysis products are used in removal of biological contaminants. The company sells its products through a network of distributors in the US. Nephros is headquartered in River Edge, New Jersey, the US.

Nephros Inc (NEPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nephros Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nephros Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nephros Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nephros Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Nephros Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nephros Inc, Medical Equipment, Deal Details 11
Partnerships 11
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters Into Licensing Agreement With Bellco 12
Nephros Enters into Agreement with CS Medical 13
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 14
Equity Offering 15
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Completes Private Placement Of US$1.2 Million 24
Nephros Completes Rights Offering Of US$1.98 Million 26
Nephros Inc – Key Competitors 28
Nephros Inc – Key Employees 29
Nephros Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Financial Announcements 31
Nov 09, 2017: Nephros Reports Third Quarter 2017 Financial Results 31
Aug 08, 2017: Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits 32
May 09, 2017: Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update 33
Mar 20, 2017: Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 34
Jan 24, 2017: Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance 36
May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 38
Mar 30, 2016: Nephros Reports 2015 Fourth Quarter and Full Year Financial Results; Provides Guidance and Potential Upcoming Milestones 40
Feb 01, 2016: Nephros Reports Preliminary 2015 Revenue and Provides Update 42
Corporate Communications 43
Nov 06, 2017: Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits 43
Feb 14, 2017: Nephros Announces Appointment of Andrew Astor as Chief Financial Officer 44
Product News 45
03/16/2016: Nephros Launches SSUmini 45
03/16/2016: Nephros Provides S100 Update 46
01/18/2016: Nephros Announces Publication of Observational Trial of DSU-D in a Hospital-Based Dialysis Facility 47
Other Significant Developments 48
Oct 16, 2017: Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue 48
Jul 10, 2017: Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance 49
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Nephros Inc, Medical Equipment, Key Facts, 2016 2
Nephros Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nephros Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nephros Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nephros Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nephros Inc, Deals By Market, 2011 to YTD 2017 9
Nephros Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters Into Licensing Agreement With Bellco 12
Nephros Enters into Agreement with CS Medical 13
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 14
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Completes Private Placement Of US$1.2 Million 24
Nephros Completes Rights Offering Of US$1.98 Million 26
Nephros Inc, Key Competitors 28
Nephros Inc, Key Employees 29

★海外企業調査レポート[Nephros Inc (NEPH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Gezhouba Group Company Limited (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Company Limited (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Ryanair Holdings plc:戦略・SWOT・企業財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cloverdale Paint Inc:企業の戦略的SWOT分析
    Cloverdale Paint Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Lay Hong Berhad (LAYHONG):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (LAYHONG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • Chariot Oil & Gas Ltd (CHAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Summer Infant, Inc.:企業の戦略・SWOT・財務情報
    Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report Summary Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Take-Two Interactive Software, Inc.:企業の戦略・SWOT・財務分析
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Orchids Paper Products Co (TIS):企業の財務・戦略的SWOT分析
    Orchids Paper Products Co (TIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Takeda Pharmaceutical Co Ltd (4502):企業の財務・戦略的SWOT分析
    Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Superior Industries International Inc (SUP):企業の財務・戦略的SWOT分析
    Superior Industries International Inc (SUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • eFront S.A.:企業の戦略的SWOT分析
    eFront S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tulane University:製薬・医療:M&Aディール及び事業提携情報
    Summary Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine, public health and tropical medicine, science, engineering, a …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Al Ain Ahlia Insurance Company PSC:企業の戦略・SWOT・財務分析
    Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report Summary Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Opthea Ltd (OPT)-製薬・医療分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆